UNSPSC 51281667: Spectinomycin dihydrochloride pentahydrate

This classification denotes an aminoglycoside antibiotic with the molecular formula C14H24N2O7.2ClH.5H2O, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier HWT06H303Z, chemically known as 4h-pyrano(2,3-b)(1,4)benzodioxin-4-one, decahydro-4a,7,9-trihydroxy-2-methyl-6,8-bis(methylamino)-, dihydrochloride, pentahydrate but more generally known as spectinomycin dihydrochloride pentahydrate, which bears US NIH Compound Identifier 30971.

European Medicines Agency schedules Spectinomycin hydrochloride in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB12327MIG. Most nations, for tariff and trade purposes, schedule spectinomycin dihydrochloride pentahydrate under HS 29419000. SMILES: C[C@@H]1CC(=O)[C@]2([C@@H](O1)O[C@@H]3[C@H]([C@@H]([C@@H]([C@@H]([C@H]3O2)NC)O)NC)O)O.O.O.O.O.O.CL.CL.

UNSPSC 51281667 Spectinomycin dihydrochloride pentahydrate is a Commodity code that covers the procurement of specific pharmaceutical active ingredients and finished pharmaceutical products by state and local health agencies. Recent state and local activity under this code shows acquisition of antibiotics and emergency-response pharmaceuticals—including broad-spectrum antimicrobials and opioid-antagonist medications—sourced through piggyback contracts and competitive bidding processes. Issuing bodies include state departments of public health and county health departments, which procure these products either directly for emergency medical stockpiles, public health preparedness initiatives, and community health programs or through established consortium purchasing vehicles such as MMCAP Infuse to access pre-negotiated pharmaceutical supplier agreements.

The code shows recent activity in Illinois and Florida. The Illinois Department of Public Health awarded a 12-month piggyback pharmaceutical warehouse contract to Chartwell Rx LLC on August 28, 2026 (Bid Number 26-482DPH-PREPD-B-53392) for supply of antibiotic tablets with a total contract value of $2,999,999.11 across all renewal periods; the award was made through an Invitation for Bid process under the MMCAP Infuse consortium. Seminole County, Florida issued an IFB (Number IFB60459723LAS) posted June 30, 2026 with a response deadline of July 26, 2023 seeking procurement of 1,900 units of Naloxone and 800 Safe Drug Deactivation Systems annually, with quarterly deliveries to the Seminole County Community Health Building in Sanford, Florida and an initial two-year term with one-year renewal option. No set-aside preferences or Business Enterprise Program utilization was identified in the Illinois award.